Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Votre recherche
Pays: Chile,Russian Federation,Hungary,Romania,France,Czech Republic,Canada,United Kingdom,Serbia - Le promoteur: Robert J. Motzer, MD
Robert J. Motzer, MD
MAJ Il y a 5 ans
A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma
This is an open-label, randomized, controlled, multi-national, multi-center, parallel-arm trial comparing tivozanib to sorafenib in subjects with advanced RCC. The study is designed to compare the PFS, OS, ORR, DR, safety and tolerability, and kidney specific symptoms/health outcome measurements of tivozanib and sorafenib.
Pays
Argentina
,
Bulgaria
,
Canada
,
Chile
,
Czech Republic
,
France
,
Hungary
,
India
,
Italy
,
Poland
,
Romania
,
Russian Federation
,
Serbia
,
Ukraine
,
United Kingdom
,
United States
,
Organes
Aucun
Spécialités
Aucun
Essai clos aux inclusions
Plus d'informations
1